-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-FDA Approves GSK's Jemperli As First Immunotherapy For MSI-H/DMMR Rectal Cancer

Reuters·10/19/2026 16:27:32

Please log in to view news